tiprankstipranks
Advertisement
Advertisement

SLDB Stock Latest News

Citizens biotech analysts hold an analyst/industry conference call
The FlyCitizens biotech analysts hold an analyst/industry conference call
19d ago
BIIB
DSGN
Solid Biosciences Shareholders Approve Directors and Share Increase
PremiumCompany Announcements
Solid Biosciences Shareholders Approve Directors and Share Increase
1M ago
8K
SLDB
Solid Biosciences price target raised to $25 from $20 at H.C. Wainwright
PremiumThe Fly
Solid Biosciences price target raised to $25 from $20 at H.C. Wainwright
2M ago
SLDB
Solid Biosciences price target lowered to $16 from $17 at Wedbush
PremiumThe Fly
Solid Biosciences price target lowered to $16 from $17 at Wedbush
2M ago
SLDB
Solid Biosciences price target raised to $18 from $17 at Piper Sandler
PremiumThe Fly
Solid Biosciences price target raised to $18 from $17 at Piper Sandler
2M ago
SLDB
Solid Biosciences doses part participant in IMPACT DUCHENNE study
PremiumThe FlySolid Biosciences doses part participant in IMPACT DUCHENNE study
2M ago
SLDB
Solid Biosciences receives orphan drug designation for SGT-003 from EC
Premium
The Fly
Solid Biosciences receives orphan drug designation for SGT-003 from EC
3M ago
SLDB
Solid Biosciences Adjusts Board Classes in Governance Move
Premium
Company Announcements
Solid Biosciences Adjusts Board Classes in Governance Move
3M ago
8K
SLDB
Solid Biosciences price target raised to $12 from $11 at JPMorgan
PremiumThe Fly
Solid Biosciences price target raised to $12 from $11 at JPMorgan
4M ago
SLDB
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
4M ago
COYA
CTMX
Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating
PremiumRatings
Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating
4M ago
SLDB
Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows
PremiumCompany Announcements
Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows
4M ago
SLDB
Guggenheim starts Solid Biosciences with a Buy on DMD gene therapy potential
PremiumThe FlyGuggenheim starts Solid Biosciences with a Buy on DMD gene therapy potential
4M ago
SLDB
SRPT
Solid Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Solid Biosciences initiated with a Buy at Guggenheim
4M ago
SLDB
Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target
Premium
Ratings
Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target
4M ago
SLDB
Solid Biosciences files to sell 1.32M shares of common stock for holders
PremiumThe Fly
Solid Biosciences files to sell 1.32M shares of common stock for holders
4M ago
SLDB
Solid Biosciences files to sell 42.78M shares of common stock for holders
PremiumThe Fly
Solid Biosciences files to sell 42.78M shares of common stock for holders
4M ago
SLDB
Solid Biosciences reports Q4 EPS (53c), consensus (52c)
PremiumThe Fly
Solid Biosciences reports Q4 EPS (53c), consensus (52c)
4M ago
SLDB
Buy Rating on SGT-003 Driven by Best-in-Class Efficacy Signals, Improving Safety, and Accelerated Approval Optionality
PremiumRatings
Buy Rating on SGT-003 Driven by Best-in-Class Efficacy Signals, Improving Safety, and Accelerated Approval Optionality
4M ago
SLDB
SLDB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsSLDB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
SLDB
Solid Biosciences price target raised to $17 from $14 at Wedbush
Premium
The Fly
Solid Biosciences price target raised to $17 from $14 at Wedbush
4M ago
SLDB
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
Premium
Ratings
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
4M ago
SLDB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >